🎗️Лента новостей
Newly discovered cell recycling pathway unlocks the therapeutic potential of TFEB
For years, TFEB has been regarded as one of the most promising therapeutic targets for restoring the cell's ability to clear and recycle waste. Yet turning that promise into therapies has proved difficult because TFEB itself is hard to target with drugs. Now, a study published in Nature by scientists at the Telethon…
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working The New York Times
Brian Mazzarella, MD, reviews early data on water vapor therapy for localized prostate cancer
Brian Mazzarella, MD, reviews early data on water vapor therapy for localized prostate cancer Urology Times
Q&A: A 5-step approach to setting achievable goals
CHICAGO — SMART goals — an approach centered on making objectives specific, measurable, achievable, relevant and time-bound — provide a useful framework for personal growth, a speaker at the Women in Medicine Summit said. However, before setting a SMART goal, physicians should first assess their readiness, confidence…
Q&A: A 5-step approach to setting achievable goals
CHICAGO — SMART goals — an approach centered on making objectives specific, measurable, achievable, relevant and time-bound — provide a useful framework for personal growth, a speaker at the Women in Medicine Summit said. However, before setting a SMART goal, physicians should first assess their readiness, confidence…
GC-OS 2026: What Not to Miss at the Global Cardio-Oncology Summit
GC-OS 2026: What Not to Miss at the Global Cardio-Oncology Summit Oncodaily
New AI platform could help cancer survivors get personalized support between doctor visits
Researchers with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have created a framework for developing, evaluating and implementing AI tools in cancer survivorship and supportive care, according to a new proof-of-concept study published in the journal Translational…
Living Three Years With Leptomeningeal Disease After Metastatic Breast Cancer
Living Three Years With Leptomeningeal Disease After Metastatic Breast Cancer Cure Today
«Святой Грааль онкологии». В США одобрили первый препарат, удваивающий выживаемость при раке поджелудочной железы
«Святой Грааль онкологии». В США одобрили первый препарат, удваивающий выживаемость при раке поджелудочной железы NV Техно
Case report highlights multidisciplinary approach to recurrent prostate cancer
A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that returns after surgery, particularly when the disease recurs multiple times and in different locations.
New Supportive Care Room Expands Cancer Survivorship Services in North Miami
New Supportive Care Room Expands Cancer Survivorship Services in North Miami University of Miami
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs
About 25% of lung adenocarcinomas have mutations of the gene KRAS, which drives uncontrolled cell growth. In recent years, the FDA has approved two KRAS inhibitors to treat patients with KRAS mutations. While these drugs can work well initially, tumors almost always develop resistance to them.